Concepedia

Publication | Open Access

Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy

43

Citations

42

References

2019

Year

Abstract

We describe a novel ACT platform with antitumor activity in murine and human tumor models with a distinct mode of action that combines adoptive T-cell therapy with bispecific antibodies.

References

YearCitations

Page 1